Histiocytic disorders

KL McClain, C Bigenwald, M Collin… - Nature Reviews …, 2021 - nature.com
The historic term 'histiocytosis' meaning 'tissue cell'is used as a unifying concept for
diseases characterized by pathogenic myeloid cells that share histological features with …

Langerhans-cell histiocytosis

CE Allen, M Merad, KL McClain - New England Journal of …, 2018 - Mass Medical Soc
Langerhans-Cell Histiocytosis A spectrum of diseases formerly known as histiocytosis X and
now called Langerhans-cell histiocytosis is characterized by ERK pathway activation …

Efficacy of MEK inhibition in patients with histiocytic neoplasms

EL Diamond, BH Durham, GA Ulaner, E Drill, J Buthorn… - Nature, 2019 - nature.com
Histiocytic neoplasms are a heterogeneous group of clonal haematopoietic disorders that
are marked by diverse mutations in the mitogen-activated protein kinase (MAPK) pathway …

Histiocytoses: emerging neoplasia behind inflammation

J Haroche, F Cohen-Aubart, BJ Rollins… - The Lancet …, 2017 - thelancet.com
Histiocytoses are disorders characterised by inflammation and the accumulation of cells
derived from the monocyte and macrophage lineages, which results in tissue damage …

Histiocytic neoplasms, version 2.2021, NCCN clinical practice guidelines in oncology

RS Go, E Jacobsen, R Baiocchi, I Buhtoiarov… - Journal of the National …, 2021 - jnccn.org
Histiocytic neoplasms are rare hematologic disorders accounting for less than 1% of cancers
of the soft tissue and lymph nodes. Clinical presentation and prognosis of these disorders …

Histiocytosis and the nervous system: from diagnosis to targeted therapies

F Cohen Aubart, A Idbaih, JF Emile, Z Amoura… - Neuro …, 2021 - academic.oup.com
Histiocytoses are heterogeneous hematopoietic diseases characterized by the accumulation
of CD68 (+) cells with various admixed inflammatory infiltrates. The identification of the …

Clinical outcomes and prognostic risk factors of Langerhans cell histiocytosis in children: results from the BCH‐LCH 2014 protocol study

L Cui, CJ Wang, HY Lian, L Zhang… - American Journal of …, 2023 - Wiley Online Library
Langerhans cell histiocytosis (LCH) is a rare myeloid neoplasm mainly affecting young
children. This study aimed to evaluate the outcomes of 449 pediatric patients enrolled in the …

Langerhans cell histiocytosis: current advances in molecular pathogenesis

T Sconocchia, J Foßelteder, G Sconocchia… - Frontiers in …, 2023 - frontiersin.org
Langerhans cell histiocytosis (LCH) is a rare and clinically heterogeneous hematological
disease characterized by the accumulation of mononuclear phagocytes in various tissues …

RAF/MEK/extracellular signal–related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions

B Hogstad, ML Berres, R Chakraborty, J Tang… - Journal of Experimental …, 2018 - rupress.org
Langerhans cell histiocytosis (LCH) is an inflammatory myeloid neoplasia characterized by
granulomatous lesions containing pathological CD207+ dendritic cells (DCs) with …

Evaluation and treatment of Langerhans cell histiocytosis patients with central nervous system abnormalities: current views and new vistas

EA Yeh, J Greenberg, O Abla, G Longoni… - Pediatric blood & …, 2018 - Wiley Online Library
Central nervous system (CNS) involvement in Langerhans cell histiocytosis (LCH) can
include mass lesions of the hypothalamic pituitary axis, choroid plexus, cerebrum, and …